Show Summary Details
Page of

Smoking cessation 

Smoking cessation
Smoking cessation

Stephen Chapman

, Grace Robinson

, John Stradling

, Sophie West

, and John Wrightson

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 January 2020

Since smoking cessation is the only real treatment to influence the long-term outcome of patients with smoking-induced COPD (and prevent its occurrence in the first place), quite rightly, great emphasis should be placed on introducing and running smoking cessation programmes. Although these should run in the community, hospital attendance is an opportunity to influence patients’ smoking. This chapter describes the smoking cessation strategies available, particularly the use of the different types of nicotine replacement therapies. In addition, the place of the newer non-nicotine replacement therapies, such as bupropion, varenicline, and others currently under investigation, is covered. The controversial electronic cigarettes are also discussed, as is the future potential for nicotine vaccines.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.